14 min read

Positioning and Outlook - 2026-10-28

General & impersonal research commentary. Not investment advice.

Published 2026-10-28

High-yield credit spreads are widening and corporate credit health remains weak even as buybacks stay near record levels, with Federal Reserve commentary and the AI earnings season the main catalysts ahead.

Recent Events

The period's policy signal came through official remarks from Warsh and Hammack on 28 and 27 October, alongside earlier scheduled appearances by Bowman and Waller, while attention was also fixed on the AI theme ahead of an earnings season framed around its quirks and conundrums. In credit, high-yield spreads were widening in the week to 22 October, and a corporate-credit health read put the average survival score at 48 out of 100, with 7,944 names flagged in danger. Buybacks remained substantial, with 13,450 active programs and $4,467 billion trailing twelve-month, up slightly from 13,373 and $4,438 billion a week earlier. Single-name news included a confidential draft IPO filing from Anthropic, reports that OpenAI plans to buy Google's AI chips, a $1.4 billion take-private offer for Wendy's from a Peltz-led group, and Jio reaching a $137 billion valuation.

Macro & policy
2026-10-28warsh: intervention_trigger
2026-10-21Five AI quirks and conundrums to watch this earnings season
2026-10-27hammack: intervention_trigger
2026-10-20Exclusive / Anthropic Draft IPO Filing Shows Red-Hot Growth, Many Risks and Massive Computing Costs
Credit & corporate
2026-10-22HY OAS Weekly: WIDENING → hold cash
2026-10-22Credit survival: avg 48/100, 7944 in danger, Altman basis: 84% measured, 13% model-N/A, 3% data gap
2026-10-22Buybacks: 13450 active, $4467B TTM
2026-10-15Buybacks: 13373 active, $4438B TTM
On the calendar
2026-10-15Bowman, Supervisory Modernization After Silicon Valley Bank
2026-10-08Waller, The Signaling Value of the Summary of Economic Projections
Notable news
2026-10-28OpenAI plans to buy Google's AI chips, The Information reports
2026-10-28Ambani’s Jio reaches $137 billion valuation, becoming India’s second-most valuable firm
2026-10-28Wendy's gets $1.4 billion take-private offer from Peltz-led group
2026-10-28CF (CF Industries Holdings, Inc.) reports earnings 2026-11-04 (8d)

Upcoming Events

The calendar ahead is thick with central-bank decisions, with the Federal Reserve, European Central Bank, and Bank of Japan all meeting within three consecutive days in late October, a cluster that leaves little breathing room for the tape to absorb each outcome before the next arrives, before the Bank of England follows in early November and the PBOC's loan prime rate fixing rounds out the stretch. Treasury supply runs alongside that, with bill and note auctions landing just ahead of the Fed, while the earnings season is in full swing with a heavy slate of reports beginning October 27. A handful of trial readouts from Vertex, AstraZeneca, Merck, and Roche are sprinkled through the same window. The shape here is dense and front-loaded, dominated by the macro spine rather than any single marquee event.

2026-10-27● phase1 readout: VX-581 (VRTX) (US)
2026-10-27● 6-Week BILL auction (US)
2026-10-27● 5-Year NOTE auction (US)
2026-10-27● 52-Week BILL auction (US)
2026-10-27● phase2 readout: Volrustomig (AZN) (US)
2026-10-28● FOMC monetary policy decision (US)
2026-10-28● phase3 readout: Belzutifan (MRK) (US)
2026-10-28● phase3 readout: RO7204239 (RHHBY) (US)
2026-10-29● ECB Governing Council monetary policy meeting (EZ)
2026-10-30● Bank of Japan Monetary Policy Meeting (JP)
2026-11-05● Bank of England MPC monetary policy decision (UK)
2026-11-20● PBOC Loan Prime Rate (LPR) fixing (CN)
Plus 2316 corporate earnings reports scheduled in the window.

Macro Projections

The near-term calendar is dense: US PCE and GDP alongside the ECB on 2026-10-29 can reset inflation, growth and European duration expectations in one pass, with the BoJ the following day able to shift JGB and yen-carry economics, and private-credit appetite tested almost immediately after by OWL/ARES earnings and then ARES/APO in early November. The direction of travel in the carry model runs toward de-escalation, with disorderly-unwind probability at 29.98%, down 4.87 points on the last step and from 39.79% earlier in its trail, a decline that is accelerating, while slow-motion crack sits at 31.44%; the credit model stays mid-range with low false-bottom risk and a falling trend to 1.9177 from 3.511, though that series ends 2026-09-30 and its current snapshot is null. Fed intervention propensity is steady at 26.33% with a 77.81% hold reading, consistent with the hold-after-September-hike coverage, and high-yield spreads at 3.30% sit wider than 3.09% on 10/7 but tighter than 3.40% on 10/22, a kernel reading of 45/100 pointing to hold. Rates look extreme in level worldwide without being synchronised in latest direction, the 30-year Treasury at 5.305% is in the 94.4th percentile, the 30-year JGB at 3.884% in the 98.8th and the 30-year Bund at 3.602% in the 91.4th, all decelerating or easing, while the 10-year gilt at 5.315% holds its 99.3rd percentile and the 10-year Treasury at 4.993% is stable in the 61.7th, with US–Japan and US–Germany 10-year spreads out at 2.169% and 1.619% showing the recent easing is happening abroad. That receding carry risk is corroborated by MOVE at 97.874 bp and VVIX at 99.45, both falling, and by VIX at 18.39 in 0.922 contango, even as SKEW at 150.97 keeps pricing fat tails; the real divergence is geopolitical, with the Geopolitical Risk index at 165.2 and Iran/Hormuz near closure sitting alongside calm credit, reinforced by the Saudi-refinery attack and reporting that diplomacy is not generating oil selling. The tension is sharpest in oil: prediction markets put WTI above $95.49 on 10/28 at 98% even as high-yield spreads hold at 3.30% and G7 FX volatility (how much the major-currency exchange rates are swinging) runs below average at z=-0.538 and falling, which is why the carry model's "FX vol elevated" tag is discounted against observed volatility. The base case is muddle-through, with roughly 35% probability that calm credit breaks by 2027-03-31, watched through high-yield spreads above 4.00% and then 4.25% and MOVE above 120 bp; if Brent holds above $110 and high-yield spreads exceed 4.00% by 2026-11-30, an inflationary slow crack follows in which energy and non-US value win while duration and US growth equities lose, and otherwise a Fed hold, range-bound credit and further carry normalisation prevail. Valuation carries the structural view: developed ex-US and EM earnings yields of 5.82% and 6.98% compare favourably with the cross-region US figure of 4.13%, while a US CAPE of 40.7 and a 2.46% implied real return leave little cushion, and asset managers' crowded 10-year long at +2.63z argues for duration selectivity rather than duration beta.

Near term ▬●●●  expires Nov 27, 2026
The latest published US high-yield OAS reading available on 2026-11-27 will be between 3.00% and 4.00%.
This is the muddle-through case. HY OAS is 3.30% and has already retraced from 3.40% on 2026-10-22; the carry model's disorderly-unwind probability is falling sharply to 29.98%, while VIX 18.39 is stable in 0.922 contango and MOVE 97.874 bp is accelerating_negative.
Cyclical ▬●●●  expires Jan 26, 2027
The Federal Reserve will not cut the federal funds target range before 2027-01-01.
prediction_edges and fed_reaction cross-validate the hold: Kalshi prices a cut before 2027 at only 6.1%, while the Fed model puts hold propensity at 77.81% and intervention propensity at a stable 26.33%. Kalshi also prices December CPI above 3.6% at 87%, and the WSJ/Reuters narrative flow describes a Fed holding after its September hike with elevated oil complicating the next move.
Cyclical ▼●●●  expires Jan 26, 2027
The first release of December 2026 US CPI will show year-over-year inflation above 3.6%.
Crowd pricing assigns 87% to this outcome. Geopolitical and news flow provide the mechanism: Iran/Hormuz is near closure, a Saudi refinery attack has revived supply concern, and oil contracts price very high spot levels.
Cyclical ▬●●●  expires Apr 26, 2027
On 2027-04-26, the US 30-year Treasury yield, DGS30, will be at or above 5.00%.
rates_curve, prediction_edges and cot_positioning cross-validate persistent duration pressure. DGS30 is 5.305%, at its 94.4th historical percentile, while JGB 30Y, Bund 30Y and gilts confirm that long-end levels are globally extreme.
Secular ▲●●●  expires Oct 28, 2027
Developed ex-US equities, represented by MSCI EAFE, will outperform US equities, represented by the S&P 500, in USD total return over the year ending 2027-10-28.
The cross-region valuation anchor shows a 5.82% developed-ex-US earnings yield versus 4.13% for the US, with EM at 6.98%. Separately, US CAPE is 40.7 and the valuation model implies only a 2.46% 10-year real return, leaving greater sensitivity to persistent global term premia.

Positioning

With high-yield credit spreads near 3.38%, the model portfolio leans into an elevated credit backdrop, and weights are scaled to conviction rather than spread evenly. Each position is sized from a screening-kernel composite that blends expected upside drift against drawdown probability, so the strongest-scoring names carry the largest equity weights while low-conviction holdings stay deliberately small. Beneath the scores sit structural mechanisms, channels such as AI narrative pressure, a Hormuz buffer ratchet and a policy reaction function, each carried with its historical hit rate over every prior firing, misses included, and discounted for what the market already prices. Those inputs are weighable, not predictive, and the holdings themselves, with weights and dossiers, follow in the tables below.

NameConviction scoreModelled drift
ET
2.69
+4.3%
NTR
2.34
+3.5%
CCJ
2.21
-0.8%
CF
2.17
+1.2%
SQM
1.49
-1.3%
NXE
1.29
-0.5%
op:china-ai-narrative-threat-v2 → the affected asset ▲ · 100% base rate · n=1op:hormuz-buffer-ratchet-v2 → the affected asset ▲ · 100% base rate · n=1op:trump-policy-reaction-function-v1 → the affected asset ▲ · 100% base rate · n=1

Model Portfolio

The model portfolio holds a deliberate split between dry powder and committed structural positions, with a substantial cash reserve set aside for staged deployment as the credit and volatility picture clarifies. The remainder of the book is built around a core of inflation-linked Treasuries across several maturities, a gold sleeve, and a quality-focused global equity allocation tilted toward the AI capex cycle, alongside a smaller position in midstream energy infrastructure. Together these sleeves express the portfolio's main structural themes rather than short-term tactical calls, leaving the deployment of cash as the primary lever as conditions evolve.

Cash 40.4%Inflation-linked 25.6%Other 16.2%Equity 11.2%Gold & metals 6.7%
NameWeightThesis
Cash · 40.4%
Money Market
40.4%
money-market / cash
Inflation-linked · 25.6%
SCHP
12.3%
inflation-linked Treasuries
VTIP
7.6%
inflation-linked Treasuries
LTPZ
5.7%
inflation-linked Treasuries
Equity · 11.2%
QUAL
11.2%
global quality equity
Other · 16.2%
KMI
4.9%
passthrough
LDOS
1.8%
critical materials defense
SPY
1.6%
model allocation
CCJ
1.5%
critical materials defense
FCX
1.3%
critical materials defense
SCCO
1.3%
critical materials defense
NXE
0.8%
critical materials defense
LIT
0.7%
critical materials defense
COPX
0.6%
critical materials defense
URA
0.5%
critical materials defense
URNM
0.3%
critical materials defense
NTR
0.3%
critical materials defense
CF
0.2%
critical materials defense
SQM
0.2%
critical materials defense
ICL
0.1%
critical materials defense
ET
0.0%
passthrough
Gold & metals · 6.7%
IAU
4.8%
gold / precious-metals
GDX
1.9%
gold / precious-metals
Position notes
KMI 4.9%
Full research note
Kinder Morgan is a midstream energy infrastructure company with regulated pipeline and terminal assets.
LDOS 1.8%
Full research note
Leidos is a U.S. government contractor providing technology services in defense, intelligence, and health markets.
CCJ 1.5%
Full research note
Cameco Corporation is a uranium producer and supplier to nuclear utilities globally.
Bull case · The strongest bull case hinges on the accelerating AI data center power buildout and Cameco's strategic downstream integration. Recent catalysts include Cameco's June 2026 move to increase its stake in the tier-one Cigar Lake mine to 57.4%, alongside Westinghouse (49% owned by Cameco) securing a central role in an $80 billion U.S. government partnership to deploy AP1000 reactors. Analysts are reiterating buys on the recent dip, citing long-term uranium contract prices hitting $90/lb in Q1 2026—the highest level since 2008—which structurally insulates the company from spot market volatility.
Bear case · The bear case focuses on severe valuation overhang and near-term execution friction. Trading at over 90x trailing earnings, the stock is highly vulnerable to multiple compression if uranium spot prices stall or if AI capex digestion delays actual reactor deployments. Furthermore, recent supply chain disruptions—such as the May 2026 bridge collapse in northern Saskatchewan that temporarily halted Key Lake and McArthur River supply lines—highlight the operational fragility of remote mining assets.
Key risks
• Severe valuation overhang leaving no margin of safety if uranium prices plateau or hyperscaler nuclear timelines slip.
• Operational and supply chain disruptions at key Saskatchewan mines, as evidenced by recent infrastructure washouts.
• AI data center capex digestion in the 2026–2027 window delaying the deployment of SMRs and new reactor builds.
• Geopolitical shifts that could unexpectedly reintroduce sanctioned Russian or Kazakh supply to Western markets, cooling the "security premium."
FCX 1.3%
Full research note
Global copper miner exposed to commodity price cycles and operational risks in Indonesia.
SCCO 1.3%
Full research note
A diversified copper miner with operations in the Americas, exposed to metal price cycles.
Bull case · Structural copper demand from electrification, renewable energy, and AI data centers supports long-term price appreciation; SCCO's industry-leading margins (gross margin ~59%, operating margin ~58%) and low cash costs provide a wide moat; the Tía María project and strong free cash flow generation (FCF margin ~29%) offer additional upside if copper prices remain elevated and the US-Iran peace deal temporarily eases inflation fears, potentially lowering the dollar.
Bear case · The stock trades at a significant premium to its sector (P/E 29.2 vs. peer median 26.1; P/B 12.3 vs. 2.2) with a consensus analyst target ~15% below current price and a majority of sell/underperform ratings; a potential copper demand slowdown from China's economic struggles or renewed trade war escalation, combined with a hawkish Fed holding rates high for longer, could compress multiples and trigger a sharp correction. Additionally, the recent Iran peace deal may reduce the 'safe-haven' premium that had supported commodity currencies and metals.
Key risks
• Severe valuation overhang: SCCO is priced for perfection, leaving no margin of safety if copper prices retreat or costs rise.
• Geopolitical and regulatory risks in Peru, including potential mining tax overhauls and anti-mining protests that could disrupt operations.
• Macro sensitivity to a strong US dollar (the DXY remains elevated) and a potential Chinese economic slowdown, both of which would directly pressure copper prices.
• Execution risk at Tía María, a greenfield project with a history of community opposition; delays or cost overruns could erode returns.
• Elevated short interest (12.1% of float, 9.0 days to cover) signals significant bearish sentiment, increasing vulnerability to a downside catalyst-driven squeeze rather than an upside one.
NXE 0.8%
Full research note
NexGen Energy is a Canadian uranium exploration and development company focused on the Rook I project.
NTR 0.3%
Full research note
Nutrien is a crop nutrient supplier with scale cost advantage from North American assets.
CF 0.2%
Full research note
A commodity nitrogen producer exposed to price and input cost volatility without differentiation.
Bull case · The strongest bull case rests on a "tighter for longer" nitrogen market combined with sharply bullish analyst revision flow. With Middle Eastern supply offline and European natural gas prices spiking, CF's North American cost advantage is generating massive free cash flow. This dynamic has triggered a powerful R19-T10 bullish revision-momentum signal, with consensus FY2026 EPS estimates surging over 70% in the last 60 days, while the Trump administration's recent permitting boost for CF's Blue Point low-carbon ammonia project adds a durable clean-energy growth vector.
Bear case · The bear case argues that CF's recent 50%+ YTD rally has fully priced in the geopolitical premium, leaving the stock highly vulnerable to a sudden de-escalation in the Middle East. If the Strait of Hormuz reopens and Middle Eastern capacity floods back into the market, global nitrogen prices will crater, rapidly compressing CF's currently inflated margins and triggering a cyclical mean-reversion selloff.
Key risks
• Geopolitical de-escalation in the Middle East rapidly normalizing global nitrogen supply.
• Cyclical mean-reversion risk following a massive 50%+ YTD rally.
• Volatility in North American natural gas prices eroding the company's structural cost advantage.
• Potential operational fatigue or unplanned outages after delaying critical maintenance at the Donaldsonville complex.
SQM 0.2%
Full research note
Chilean producer of specialty plant nutrients, iodine, and lithium chemicals with volatile commodity prices.
ICL 0.1%
Full research note
ICL Group mines specialty minerals for agriculture and industrial uses, facing concession and commodity risks.
ET 0.0%
Full research note
Midstream energy company operating pipelines and storage with commodity and regulatory risks.

Track Record

Since the model portfolio's inception on August 21, 2026, it has returned -4.61% through October 27, trailing a daily-rebalanced 60/40 SPY/AGG benchmark by 4.41 percentage points over 47 trading days. Across the 68 days of evaluated ideas, per-pick alpha has been consistently negative at every matured horizon: hit rates of 36% at one day, 41% at one week, and 21% at four weeks, with mean alpha of -0.4%, -0.9%, and -3.1% respectively. Those figures rest on a limited sample, 428 one-day observations, 374 at one week, and just 107 at four weeks, and the first three-month outcomes do not begin maturing until roughly November 20. Every call is logged before the outcome is known and scored when its horizon arrives, so the record above is reported as realized, not selected.

-4.61%
Model portfolio return
since 2026-08-21, vs 60/40 (SPY/AGG, daily-rebalanced) -0.19%
21%
Per-pick hit rate
4w, n=107
-3.1%
Mean alpha (4w)
-2.0%
Mean return (4w)

Macro forecasts: 451 graded, 1454 open — each call is scored against what actually happened when its horizon arrived.

Positions, conflicts & disclosures

DISCLAIMER — NOT INVESTMENT ADVICE (DECISION-LINKED)

This publication provides GENERAL and IMPERSONAL commentary and analysis on a regular schedule. The same content is provided to every subscriber. It is NOT investment advice, is NOT tailored to any individual, and does NOT account for your personal financial situation, objectives, or risk tolerance.

This post reports (1) a rules-based MODEL portfolio — target weights produced by an automated system's published rules, identical for all readers — and (2) DECISION-LINKED activity: how that affiliated automated system actually implemented, or has queued to implement, those rules in accounts belonging to the publication's operator. Model weights are not an account statement; the decision-linked positions and pending orders are REAL and belong to accounts affiliated with this publication's operator. We publish them for transparency on a fixed schedule under our Trading & Publication Policy [link] — not as a recommendation that any security or strategy is suitable for you. Because the publisher and/or operator hold or intend to establish positions in the securities discussed, a conflict of interest exists and our interests may differ from yours.

Nothing here is a recommendation to buy, sell, or hold any security for you specifically. Investing involves risk, including loss of principal. Past performance — model or actual — does not guarantee future results.

[Publisher LLC] is not a registered investment adviser and does not provide individualized investment advice. Consult a licensed professional before making any investment decision. See full disclosures, methodology, and our Trading & Publication Policy at [link].

POSITIONS DISCLOSURE: this is a hypothetical, rules-based model portfolio, not a statement of any individual's actual account; the publisher and/or author may hold positions in one or more of the securities listed.

CONFLICT OF INTEREST: because the publisher and/or author may hold listed securities, a conflict of interest exists and could benefit from price movements; the publisher receives no compensation for featuring any security, and this impersonal model illustration is not personalized investment advice or a solicitation to transact.

MICRO-CAP CAVEAT: some listed names are micro-capitalization securities held at small model weights; micro-caps carry elevated liquidity and volatility risk and are unsuitable for short-term trading — the small weights reflect that risk, and nothing here is a recommendation to scalp or rapidly trade thinly-traded securities.

Intended transactions: the affiliated automated system has open or queued target allocations in the following securities discussed here: SPY. These are real pending orders or model target weights in accounts belonging to the publication's operator, disclosed for transparency under our Trading & Publication Policy [link] — not a recommendation, and our interests may differ from yours.

Positions held: the publisher and/or operator currently holds positions in the following securities discussed here: CCJ, CF, COPX, ET, FCX, GDX, IAU, ICL, KMI, LDOS, LIT, LTPZ, NTR, NXE, QUAL, SCCO, SCHP, SQM, URA, URNM, VTIP.

Disclaimer — not investment advice

This publication is a bona fide financial publication of general and regular circulation. It provides GENERAL and IMPERSONAL commentary and analysis only. The same content is provided to every reader on a regular schedule. It is NOT investment advice, is NOT tailored to any individual, and does NOT account for your personal financial situation, objectives, or risk tolerance.

Nothing here is a recommendation to buy, sell, or hold any security for you specifically. Any model portfolio described is a rules-based, hypothetical illustration provided to all readers identically — it is not a recommendation personalized to you. Investing involves risk, including loss of principal. Past performance — and any hypothetical or backtested performance — does not guarantee future results.

Clarke Envoy is not a registered investment adviser and does not provide individualized investment advice. Consult a licensed professional before making any investment decision.